Recurrence Rate
Recurrence Rate - Related Videos
05:25
Identification and Protection of the Recurrent Laryngeal Nerve during Transoral Robotic Thyroidectomy
0 Views •
2025
The aim of this article is to present a method for identifying and protecting the recurrent laryngeal nerve during robotic thyroidectomy through the oral vestibular approach in the absence of the laryngeal nerve monitor.
07:27
Recurrent Herpetic Stromal Keratitis in Mice, a Model for Studying Human HSK
0 Views •
Cited by 17 •
2012
Most studies of herpetic corneal disease use a primary infection model. However, primary infection with HSV-1 does not typically lead to human disease. Here we describe a recurrent model of herpetic corneal disease, which more closely mimics human disease.
06:15
Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma
0 Views •
Cited by 15 •
2014
A novel methodology that is employed for the treatment of recurrent glioblastomas is described. This treatment approach employs the application of alternating electric tumor treating fields (TTFields), known as TTF Therapy in combination with bevacizumab, a targeted agent that is currently FDA approved as monotherapy.
01:27
Enhancing Drug Delivery in Recurrent Glioblastoma with Laser-Induced Hyperthermia
0 Views •
2025
Begin with an anesthetized human patient diagnosed with recurrent glioblastoma, an invasive tumor characterized by tumor cell infiltration into the surrounding peritumoral region.The peritumoral region retains an intact blood-brain barrier (BBB), where tight junctions between endothelial cells restrict drug penetration.Make an incision in the scalp, create an opening in the skull, and insert a laser probe into the tumor core using MRI guidance.Deliver laser light through the probe.Tissue...
10:49
Estimating Virus Production Rates in Aquatic Systems
0 Views •
Cited by 8 •
2010
The turnover rate of viruses in marine and freshwater systems can be estimated by a reduction and reoccurrence technique. The data allow researchers to infer rates of virus-mediated microbial mortality in aquatic systems.
FAQs
Researchers first count only episodes that satisfy a prespecified recurrence definition, then relate those events either to the number of patients under observation or to the time they were observed. The chosen denominator changes how results are expressed, so comparisons are most meaningful when studies use clearly described, compatible calculation approaches.
Separating recurrence from persistence and a new condition protects the estimate from mixing clinically different events. A condition that never fully resolved is not interpreted the same way as one that returned after remission, and an unrelated diagnosis should not automatically be counted as disease return. This distinction makes long-term outcomes easier to interpret.
Case definitions and follow-up duration strongly shape the measured rate. If investigators change which episodes qualify, studies may count different events even in similar populations. Inadequate follow-up can miss later returns, while an explicitly defined patient population and observation period make the estimate more interpretable and help researchers examine factors associated with recurrence.
To compare treatments fairly, investigators need the same recurrence criteria and sufficiently clear follow-up for each group. They can then examine how often qualifying events occur and whether particular factors are associated with disease return. The resulting comparison informs evaluation of long-term outcomes, but its meaning depends on how consistently recurrence was identified and measured.
Investigators define the patient population, specify in advance what counts as recurrence, follow participants for a stated period, and identify new episodes that meet that definition. They then relate the observed events to the number of patients or the time observed. Reporting these choices allows readers to understand and interpret the estimate.
Recurrence rate is useful when medicine requires more than an immediate treatment result. Researchers can use it to compare therapies, investigate factors associated with disease return, evaluate long-term outcomes, and design follow-up strategies around observed patterns. Its value extends across diseases and clinical events, provided the underlying definitions and observation periods are clear.
During counseling, recurrence information helps clinicians explain why follow-up may remain important after remission or an initial episode. A reported rate can summarize how often return was observed in a defined population and period, while the case definition clarifies what was counted. This supports more precise discussions of long-term outcomes without conflating persistence or new conditions with recurrence.